• Musol® oral solution contains Ambroxol that is a metabolite of Bromhexine which is used similarly as a  mucolytic.
  • Ambroxol acts by alteration the structure of mucus to decrease its viscosity there by facilitating its removal by ciliary active expectoration.

Each 5 ml Musol® oral solution contains:

  •    Ambroxol hydrochloride  15 mg.

Each 1 ml Musol® oral drops contains:

  •    Ambroxol hydrochlorid    7.5 mg.
  • Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
  • Hypersensitivity to Ambroxol.
  • Following the administration of Ambroxol,concentrations of some antibiotics (Amoxicilline, Cefuroxime, Erythromycin) in bronchopulmonary secretions and in the sputum are increased.
  • No clinically relevant unfavorable interaction with other medications has been reported.  
  • Ambroxol crosses the placental barrier. Extensive clinical experience after the 28th week of pregnancy has shown no evidence of harmful effects on the fetus. Nonetheless, the usual precautions regarding the use of drugs during pregnancy should be observed. Especially during the first trimester, the use of Musol® is not recommended.   
  • Ambroxol is excreted in breast milk.Therefore, Musol® is not recommended for use in nursing mothers. However, unfavorable effects on breastfed infants would not be expected.
  • Musol® is generally well tolerated.
  • Gastro-intestinal Disorders: pyrosis, dyspepsia, nausea,vomiting, diarrhea and other mild gastro-intestinal  symptoms.
  • Immune System Disorders, Skin and Subcutaneous Tissue Disorders: Rash, urticaria, angio-oedema, anaphylactic reactions (including anaphylactic shock) and other allergic reactions.

Over dosage:
A) Symptoms of intoxication:

  • Ambroxol was well tolerated on oral doses of up to 25 mg/kg/ day.
  • Extreme over dose should cause increased salivation,  retching, vomiting and fall in blood pressure. 

b) Treatment of intoxication:

  • In case of extreme over dose the circulation should be  monitored and, if necessary, symptomatic treatment initiated. 
  • Gastric lavage and  inducing vomiting are not generally recommended and should only be considered in the event of an extreme over dose.

Adults & children over 12 years:

  • 10 ml Musol® oral solution 3 times daily.

(This regimen is suitable for the therapy of acute respiratory tract disorders and for the initial treatment of chronic conditions up to 14 days).

Children under12 years ( syrup ):

Children ( 6 - 12 years):

  • (5 ml) 2 to 3 times per day .

Children ( 2 - 6 years):

  • (2.5 ml) 2 to 3 times per day.

Children (under 2 years):

  • (2.5 ml) 2 times per day.   

Children under12 years (dsrops ):

Children ( 6 - 12 years):

  • (2 ml) 2 to 3 times per day

Children ( 2 - 6 years):

  • (1 ml) 2 to 3  times per day

Children (under 2 years):

  • (1ml) 2 times per day

¤ Musol® should be taken at mealtimes.

  • Musol® may have a mild laxative effect.
  • Musol® oral solution: (Bottle of 100 ml).
  • Musol® oral drops: (Bottle of 30 ml).
  • Store below 25°C.